Sennoside C

CAS : 37271-16-2

Ref. 3D-MS74107

Informations sur le produit

• Nom: Sennoside C
• Synonymes: (9,9'-Bianthracene)-2-carboxylic acid, 5,5'-bis(beta-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-2'-(hydroxymethyl)-10,10'-dioxo-, (R*,R*)-, 5,5'-bis(beta-D-glucopyranosyloxy)-4,4'-dihydroxy-2'-(hydroxymethyl)-10,10'-dioxo-9,9',10,10'-tetrahydro-9,9'-bianthracene-2-carboxylic acid, [9,9′-Bianthracene]-2-carboxylic acid, 5,5′-bis(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-2′-(hydroxymethyl)-10,10′-dioxo-, (9R,9′R)-rel-, [9,9′-Bianthracene]-2-carboxylic acid, 5,5′-bis(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-2′-(hydroxymethyl)-10,10′-dioxo-, (R*,R*)-, rel-(9R,9′R)-5,5′-Bis(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-2′-(hydroxymethyl)-10,10′-dioxo[9,9′-bianthracene]-2-carboxylic acid

Description

Sennoside C is a bioactive phytochemical extracted from the leaves of Eclipta prostrata. It has been shown to have anti-tumor and anti-inflammatory properties. Sennoside C has also been found to be effective in treating autoimmune diseases, including psoriasis and rheumatoid arthritis. Sennoside C is a low-energy compound that binds with fatty acids to form a bound form. This bound form can be hydrolyzed by sodium hydroxide solution to release free sennosides, which are anthraquinone glycosides that can be used for the treatment of skin conditions such as eczema and dermatitis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 848.76 g/mol
• Formule: C₄₂H₄₀O₁₉
• Degré de pureté: Min. 95%
• Couleur/Forme: Solid